Global Enterovirus Vaccine Market Research Report 2026(Status and Outlook)

March 2026 | 134 pages | ID: G89C31A53004EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccinesThe global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Enterovirus Vaccine market size was estimated at USD 362.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Enterovirus Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Enterovirus Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Enterovirus Vaccine market.

Global Enterovirus Vaccine Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Sinovac Biotech
Medigen Vaccine Biologics
Shenzhen Neptunus
Sinopharm
Adimmune
Intravacc
Shanghai Zerun Biotechnology
Beijing Minhai Biotechnology

Market Segmentation (by Type)

Coxasckievirus A
Coxasckievirus B
Human Enterovirus 71
Others

Market Segmentation (by Application)

Hospital
Research Institute
Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Enterovirus Vaccine Market
Overview of the regional outlook of the Enterovirus Vaccine Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Enterovirus Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Enterovirus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Enterovirus Vaccine
1.2 Key Market Segments
  1.2.1 Enterovirus Vaccine Segment by Type
  1.2.2 Enterovirus Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ENTEROVIRUS VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Enterovirus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Enterovirus Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ENTEROVIRUS VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Enterovirus Vaccine Product Life Cycle
3.3 Global Enterovirus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Enterovirus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Enterovirus Vaccine Market Competitive Situation and Trends
  3.8.1 Enterovirus Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Enterovirus Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ENTEROVIRUS VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Enterovirus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ENTEROVIRUS VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Enterovirus Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Enterovirus Vaccine Market
5.7 ESG Ratings of Leading Companies

6 ENTEROVIRUS VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Enterovirus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Enterovirus Vaccine Market Size by Type (2020-2025)
6.4 Global Enterovirus Vaccine Price by Type (2020-2025)

7 ENTEROVIRUS VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Enterovirus Vaccine Market Sales by Application (2020-2025)
7.3 Global Enterovirus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Enterovirus Vaccine Sales Growth Rate by Application (2020-2025)

8 ENTEROVIRUS VACCINE MARKET SALES BY REGION

8.1 Global Enterovirus Vaccine Sales by Region
  8.1.1 Global Enterovirus Vaccine Sales by Region
  8.1.2 Global Enterovirus Vaccine Sales Market Share by Region
8.2 Global Enterovirus Vaccine Market Size by Region
  8.2.1 Global Enterovirus Vaccine Market Size by Region
  8.2.2 Global Enterovirus Vaccine Market Size by Region
8.3 North America
  8.3.1 North America Enterovirus Vaccine Sales by Country
  8.3.2 North America Enterovirus Vaccine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Enterovirus Vaccine Sales by Country
  8.4.2 Europe Enterovirus Vaccine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Enterovirus Vaccine Sales by Region
  8.5.2 Asia Pacific Enterovirus Vaccine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Enterovirus Vaccine Sales by Country
  8.6.2 South America Enterovirus Vaccine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Enterovirus Vaccine Sales by Region
  8.7.2 Middle East and Africa Enterovirus Vaccine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ENTEROVIRUS VACCINE MARKET PRODUCTION BY REGION

9.1 Global Production of Enterovirus Vaccine by Region(2020-2025)
9.2 Global Enterovirus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Enterovirus Vaccine Production
  9.4.1 North America Enterovirus Vaccine Production Growth Rate (2020-2025)
  9.4.2 North America Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Enterovirus Vaccine Production
  9.5.1 Europe Enterovirus Vaccine Production Growth Rate (2020-2025)
  9.5.2 Europe Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Enterovirus Vaccine Production (2020-2025)
  9.6.1 Japan Enterovirus Vaccine Production Growth Rate (2020-2025)
  9.6.2 Japan Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Enterovirus Vaccine Production (2020-2025)
  9.7.1 China Enterovirus Vaccine Production Growth Rate (2020-2025)
  9.7.2 China Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Sinovac Biotech
  10.1.1 Sinovac Biotech Basic Information
  10.1.2 Sinovac Biotech Enterovirus Vaccine Product Overview
  10.1.3 Sinovac Biotech Enterovirus Vaccine Product Market Performance
  10.1.4 Sinovac Biotech Business Overview
  10.1.5 Sinovac Biotech SWOT Analysis
  10.1.6 Sinovac Biotech Recent Developments
10.2 Medigen Vaccine Biologics
  10.2.1 Medigen Vaccine Biologics Basic Information
  10.2.2 Medigen Vaccine Biologics Enterovirus Vaccine Product Overview
  10.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Product Market Performance
  10.2.4 Medigen Vaccine Biologics Business Overview
  10.2.5 Medigen Vaccine Biologics SWOT Analysis
  10.2.6 Medigen Vaccine Biologics Recent Developments
10.3 Shenzhen Neptunus
  10.3.1 Shenzhen Neptunus Basic Information
  10.3.2 Shenzhen Neptunus Enterovirus Vaccine Product Overview
  10.3.3 Shenzhen Neptunus Enterovirus Vaccine Product Market Performance
  10.3.4 Shenzhen Neptunus Business Overview
  10.3.5 Shenzhen Neptunus SWOT Analysis
  10.3.6 Shenzhen Neptunus Recent Developments
10.4 Sinopharm
  10.4.1 Sinopharm Basic Information
  10.4.2 Sinopharm Enterovirus Vaccine Product Overview
  10.4.3 Sinopharm Enterovirus Vaccine Product Market Performance
  10.4.4 Sinopharm Business Overview
  10.4.5 Sinopharm Recent Developments
10.5 Adimmune
  10.5.1 Adimmune Basic Information
  10.5.2 Adimmune Enterovirus Vaccine Product Overview
  10.5.3 Adimmune Enterovirus Vaccine Product Market Performance
  10.5.4 Adimmune Business Overview
  10.5.5 Adimmune Recent Developments
10.6 Intravacc
  10.6.1 Intravacc Basic Information
  10.6.2 Intravacc Enterovirus Vaccine Product Overview
  10.6.3 Intravacc Enterovirus Vaccine Product Market Performance
  10.6.4 Intravacc Business Overview
  10.6.5 Intravacc Recent Developments
10.7 Shanghai Zerun Biotechnology
  10.7.1 Shanghai Zerun Biotechnology Basic Information
  10.7.2 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Overview
  10.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Market Performance
  10.7.4 Shanghai Zerun Biotechnology Business Overview
  10.7.5 Shanghai Zerun Biotechnology Recent Developments
10.8 Beijing Minhai Biotechnology
  10.8.1 Beijing Minhai Biotechnology Basic Information
  10.8.2 Beijing Minhai Biotechnology Enterovirus Vaccine Product Overview
  10.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Product Market Performance
  10.8.4 Beijing Minhai Biotechnology Business Overview
  10.8.5 Beijing Minhai Biotechnology Recent Developments

11 ENTEROVIRUS VACCINE MARKET FORECAST BY REGION

11.1 Global Enterovirus Vaccine Market Size Forecast
11.2 Global Enterovirus Vaccine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Enterovirus Vaccine Market Size Forecast by Country
  11.2.3 Asia Pacific Enterovirus Vaccine Market Size Forecast by Region
  11.2.4 South America Enterovirus Vaccine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Enterovirus Vaccine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Enterovirus Vaccine Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Enterovirus Vaccine by Type (2026-2035)
  12.1.2 Global Enterovirus Vaccine Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Enterovirus Vaccine by Type (2026-2035)
12.2 Global Enterovirus Vaccine Market Forecast by Application (2026-2035)
  12.2.1 Global Enterovirus Vaccine Sales (K Units) Forecast by Application
  12.2.2 Global Enterovirus Vaccine Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Enterovirus Vaccine Market Size by Type (M USD)
Table 4. Global Enterovirus Vaccine Market Size by Application
Table 5. Enterovirus Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Enterovirus Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Enterovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Enterovirus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Enterovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2025)
Table 11. Global Market Enterovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Enterovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Enterovirus Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Enterovirus Vaccine Sales by Type (K Units)
Table 27. Global Enterovirus Vaccine Market Size by Type (M USD)
Table 28. Global Enterovirus Vaccine Sales (K Units) by Type (2020-2025)
Table 29. Global Enterovirus Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Enterovirus Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Enterovirus Vaccine Market Share by Type (2020-2025)
Table 32. Global Enterovirus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 33. Global Enterovirus Vaccine Sales (K Units) by Application
Table 34. Global Enterovirus Vaccine Market Size by Application
Table 35. Global Enterovirus Vaccine Sales by Application (2020-2025) & (K Units)
Table 36. Global Enterovirus Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Enterovirus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Enterovirus Vaccine Market Share by Application (2020-2025)
Table 39. Global Enterovirus Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Enterovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 41. Global Enterovirus Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Enterovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Enterovirus Vaccine Market Size by Region (2020-2025)
Table 44. North America Enterovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. North America Enterovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Enterovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Europe Enterovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Enterovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Enterovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Enterovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 51. South America Enterovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Enterovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Enterovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Enterovirus Vaccine Production (K Units) by Region(2020-2025)
Table 55. Global Enterovirus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Enterovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Sinovac Biotech Basic Information
Table 63. Sinovac Biotech Enterovirus Vaccine Product Overview
Table 64. Sinovac Biotech Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Sinovac Biotech Business Overview
Table 66. Sinovac Biotech SWOT Analysis
Table 67. Sinovac Biotech Recent Developments
Table 68. Medigen Vaccine Biologics Basic Information
Table 69. Medigen Vaccine Biologics Enterovirus Vaccine Product Overview
Table 70. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Medigen Vaccine Biologics Business Overview
Table 72. Medigen Vaccine Biologics SWOT Analysis
Table 73. Medigen Vaccine Biologics Recent Developments
Table 74. Shenzhen Neptunus Basic Information
Table 75. Shenzhen Neptunus Enterovirus Vaccine Product Overview
Table 76. Shenzhen Neptunus Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Shenzhen Neptunus Business Overview
Table 78. Shenzhen Neptunus SWOT Analysis
Table 79. Shenzhen Neptunus Recent Developments
Table 80. Sinopharm Basic Information
Table 81. Sinopharm Enterovirus Vaccine Product Overview
Table 82. Sinopharm Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sinopharm Business Overview
Table 84. Sinopharm Recent Developments
Table 85. Adimmune Basic Information
Table 86. Adimmune Enterovirus Vaccine Product Overview
Table 87. Adimmune Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Adimmune Business Overview
Table 89. Adimmune Recent Developments
Table 90. Intravacc Basic Information
Table 91. Intravacc Enterovirus Vaccine Product Overview
Table 92. Intravacc Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Intravacc Business Overview
Table 94. Intravacc Recent Developments
Table 95. Shanghai Zerun Biotechnology Basic Information
Table 96. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Overview
Table 97. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Shanghai Zerun Biotechnology Business Overview
Table 99. Shanghai Zerun Biotechnology Recent Developments
Table 100. Beijing Minhai Biotechnology Basic Information
Table 101. Beijing Minhai Biotechnology Enterovirus Vaccine Product Overview
Table 102. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Minhai Biotechnology Business Overview
Table 104. Beijing Minhai Biotechnology Recent Developments
Table 105. Global Enterovirus Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 106. Global Enterovirus Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Enterovirus Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 108. North America Enterovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Enterovirus Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 110. Europe Enterovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Enterovirus Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 112. Asia Pacific Enterovirus Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Enterovirus Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 114. South America Enterovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Enterovirus Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Enterovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Enterovirus Vaccine Sales Forecast by Type (2026-2035) & (K Units)
Table 118. Global Enterovirus Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Enterovirus Vaccine Price Forecast by Type (2026-2035) & (USD/Unit)
Table 120. Global Enterovirus Vaccine Sales (K Units) Forecast by Application (2026-2035)
Table 121. Global Enterovirus Vaccine Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Enterovirus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Enterovirus Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Enterovirus Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Enterovirus Vaccine Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Enterovirus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Enterovirus Vaccine Product Life Cycle
Figure 13. Enterovirus Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Enterovirus Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Enterovirus Vaccine Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Enterovirus Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Enterovirus Vaccine
Figure 19. Global Enterovirus Vaccine Market PEST Analysis
Figure 20. Global Enterovirus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Enterovirus Vaccine Market Share by Type
Figure 27. Sales Market Share of Enterovirus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Enterovirus Vaccine by Type in 2025
Figure 29. Market Share of Enterovirus Vaccine by Type (2020-2025)
Figure 30. Market Share of Enterovirus Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Enterovirus Vaccine Market Share by Application
Figure 33. Global Enterovirus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Enterovirus Vaccine Sales Market Share by Application in 2025
Figure 35. Global Enterovirus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Enterovirus Vaccine Market Share by Application in 2025
Figure 37. Global Enterovirus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Enterovirus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Enterovirus Vaccine Market Size by Region (2020-2025)
Figure 40. North America Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Enterovirus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Enterovirus Vaccine Market Size by Country in 2024
Figure 45. U.S. Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Enterovirus Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Enterovirus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Enterovirus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Enterovirus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Enterovirus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Enterovirus Vaccine Market Size by Country in 2024
Figure 55. Germany Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Enterovirus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Enterovirus Vaccine Market Size by Region in 2024
Figure 68. China Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Enterovirus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Enterovirus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Enterovirus Vaccine Market Size by Country in 2024
Figure 82. Brazil Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Enterovirus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Enterovirus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Enterovirus Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Enterovirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Enterovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Enterovirus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Enterovirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Enterovirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Enterovirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Enterovirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Enterovirus Vaccine Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Enterovirus Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Enterovirus Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Enterovirus Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Enterovirus Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Enterovirus Vaccine Market Share Forecast by Application (2026-2035)


More Publications